Cerebrovascular accidents in elderly people treated with antipsychotic drugs: a systematic review.
about
Antidepressants for agitation and psychosis in dementiaCurcumin Mitigates the Intracellular Lipid Deposit Induced by Antipsychotics In VitroInvestigational drugs for treating agitation in persons with dementia.Antipsychotic medications and stroke in schizophrenia: A case-crossover study.Quantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults: systematic review and meta-synthesis.Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic review.Movement disorders in elderly users of risperidone and first generation antipsychotic agents: a Canadian population-based studyCardiovascular and cerebrovascular risk factors and events associated with second-generation antipsychotic compared to antidepressant use in a non-elderly adult sample: results from a claims-based inception cohort study.Risk of ischemic stroke associated with the use of antipsychotic drugs in elderly patients: a retrospective cohort study in Korea.Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.Myocardial infarction risk and antipsychotics use revisited: a meta-analysis of 10 observational studies.Prescribing of psychotropic medications to the elderly population of a Canadian province: a retrospective study using administrative databases.Risk of cerebrovascular adverse events and death in elderly patients with dementia when treated with antipsychotic medications: a literature review of evidence.Prescribing for older people in nursing homes: a review of the key issues.Drug therapy optimization at the end of life.Adverse drug events as a cause of hospitalization in older adults.Risk of ischemic stroke with the use of risperidone, quetiapine and olanzapine in elderly patients: a population-based, case-crossover study.The genetics of vascular incidents associated with second-generation antipsychotic administration.A comparison of risperidone and haloperidol for the risk of ischemic stroke in the elderly: a propensity score-matched cohort analysis.AVP-786 for the treatment of agitation in dementia of the Alzheimer's type.The Risk of Thromboembolism in Users of Antidepressants and Antipsychotics.Hallucinations Predict Relapse After Discontinuation of Risperidone in Patients With Alzheimer's Disease and Psychosis or Agitation.Psychotropic drug use in relation to mental disorders and institutionalization among 95-year-olds: a population-based study.Second-generation antipsychotic drug use in hospital inpatients with dementia: the impact of a safety warning on rates of prescribing.Case-crossover studies of therapeutics: design approaches to addressing time-varying prognosis in elderly populations.Evidence and decision algorithm for the withdrawal of antipsychotic treatment in the elderly with dementia and neuropsychiatric symptoms.Cognitive performance of long-term institutionalized elderly patients with schizophrenia: A case control study.Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review.Adverse Drug Reactions, Power, Harm Reduction, Regulation and the ADRe Profiles
P2860
Q24236550-253FF390-CB7C-4E35-A8FB-43BBAC7D5158Q28550570-6B52BB6A-D117-4515-A1E2-497929A62C56Q30250076-C93C3F08-9651-4C1B-ACFB-7027B89AA5CBQ33797537-7B7BD74E-8252-4DAF-B9B6-8303F15138B3Q34070862-E6D5F28A-5722-445B-8464-504882F63F3BQ34298335-2F426886-AED1-4256-9A3E-5865B52DC047Q34734083-3081B073-0EE8-4BA0-81D0-0B6D02A5315DQ35087495-EDBBD315-519C-4B0B-8DFC-F4CC99FA99EDQ35196617-3500CA31-8A62-4C1F-B2A2-9CC87D809E21Q35754726-5FF9911D-86C2-45A3-A035-99318B762E7AQ36405036-C7A4EF7F-FCC5-4A75-8F02-1B10A6993DFEQ37219314-FEFE1ECF-8C6C-4272-95FD-159BDF50FA96Q37833824-B48CE5CA-6386-4B26-B3E1-D9CAD8196B5DQ37837997-BC2FD577-1682-43A4-8D5E-45621F924730Q38014128-4229D15F-E727-4AB7-8258-85EDFD06E245Q38085222-59E3BACF-3C68-4F29-A655-6A595C6F952CQ38093726-B2406EF4-9C08-4410-A491-549DF0F73BB5Q38170191-242553FB-394E-4146-AE07-88C68DCB7967Q38397919-455CFACB-BA77-490F-B350-ABC1C36C398DQ39034436-7CE64EC3-6043-47AB-805A-DE1B392D4875Q40577573-A177F189-D842-4975-9D04-8456B3EDD142Q41279177-559900B7-9A7F-4FB6-B8F4-FE783D7C6146Q45346494-066266FB-22ED-49D3-B0FA-B79E621956F1Q46100895-4AD39023-86EB-4459-BF91-ABBDD60C9305Q46864781-9BF995E7-2C0E-4A86-83F8-27E4963730D0Q47737322-E0E18471-B479-49EE-8ABB-0C2AD28232CBQ50043548-9D573F6E-2DFB-41F8-8C11-342F2B97FA77Q55000556-B362FACB-EA8D-421A-88C0-C8013E13E61CQ58722388-20D2ECF0-E774-403F-84A6-FC3CF67EB40B
P2860
Cerebrovascular accidents in elderly people treated with antipsychotic drugs: a systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cerebrovascular accidents in e ...... ic drugs: a systematic review.
@en
Cerebrovascular accidents in e ...... ic drugs: a systematic review.
@nl
type
label
Cerebrovascular accidents in e ...... ic drugs: a systematic review.
@en
Cerebrovascular accidents in e ...... ic drugs: a systematic review.
@nl
prefLabel
Cerebrovascular accidents in e ...... ic drugs: a systematic review.
@en
Cerebrovascular accidents in e ...... ic drugs: a systematic review.
@nl
P2860
P1433
P1476
Cerebrovascular accidents in e ...... ic drugs: a systematic review.
@en
P2093
Paolo Valsecchi
P2860
P304
P356
10.2165/11319120-000000000-00000
P577
2010-04-01T00:00:00Z
P6179
1048703620